{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:51:10Z","timestamp":1779259870995,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.xcrm.2023.101293","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:36:21Z","timestamp":1700566581000},"page":"101293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Jonathan","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Colon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Defne","family":"Bayik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3168-7290","authenticated-orcid":false,"given":"Justin D.","family":"Lathia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101293_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2159-8290.CD-19-0400","article-title":"Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101293_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051176","article-title":"Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy","volume":"14","author":"Park","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101293_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2021.02.004","article-title":"Context-Dependent Glioblastoma-Macrophage\/Microglia Symbiosis and Associated Mechanisms","volume":"42","author":"Xuan","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2023.101293_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuonc\/nov245","article-title":"Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study","volume":"18","author":"Butowski","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2023.101293_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2023.101293_bib6","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102030","article-title":"Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis","volume":"39","author":"Jacobs","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2023.101293_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091280","article-title":"STAT3, a Master Regulator of Anti-Tumor Immune Response","volume":"11","author":"R\u00e9b\u00e9","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101293_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.xcrm.2023.101293_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2019.12.013","article-title":"Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1\/STAT1 activation","volume":"472","author":"Shen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2023.101293_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/2326-6066.CIR-21-0559","article-title":"Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma","volume":"10","author":"Xuan","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2023.101293_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.101238","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Reports Medicine"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T01:03:50Z","timestamp":1770858230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123004871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666379123004871"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101293","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101238","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101293"}}